Keratitis Clinical Trial
Official title:
Deep Learning for the Discrimination Among Bacterial, Fungal, Viral, Amebic and Noninfectious Keratitis: a Nationwide Study
Detecting the cause of keratitis fast is the premise of providing targeted therapy for reducing vision loss and preventing severe complications. Due to overlapping inflammatory features, even expert cornea specialists have relatively poor performance in the identification of causative pathogen of infectious keraitis. In this project, the investigators aim to develop an automated and accurate deep learning system to discriminate among bacterial, fungal, viral, amebic and noninfectious keratitis based on slit-lamp images and evaluated this system using the datasets obtained from mutiple independent clinical centers across China.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00513734 -
A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill
|
N/A | |
Enrolling by invitation |
NCT03436576 -
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
|
Phase 3 | |
Recruiting |
NCT06229379 -
The Effects of a Large Language Model on Clinical Questioning Skills
|
N/A | |
Completed |
NCT01268306 -
Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses
|
Phase 4 | |
Completed |
NCT01028027 -
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
|
Phase 3 | |
Recruiting |
NCT05432336 -
Complex Ocular Infection, Optimization of Microbiological Diagnosis
|
||
Completed |
NCT04169061 -
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
|
Phase 4 | |
Completed |
NCT03237936 -
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
|
Phase 4 | |
Completed |
NCT00001734 -
Screening for NEI Clinical Studies
|
N/A | |
Recruiting |
NCT05255016 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
|
Phase 2/Phase 3 | |
Recruiting |
NCT05255107 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
|
Phase 2/Phase 3 | |
Terminated |
NCT05250583 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
|
Phase 2 | |
Recruiting |
NCT02865876 -
Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis
|
Phase 3 | |
Terminated |
NCT02116062 -
Robotic Surgery of the Ocular Surface
|
N/A | |
Recruiting |
NCT00838422 -
Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound
|
N/A | |
Completed |
NCT00949468 -
Microbiological Keratitis in a Countryside City of Brazil
|
N/A | |
Completed |
NCT03586505 -
Tolerance to Light for Patients Suffering From Keratitis
|
N/A | |
Recruiting |
NCT04420962 -
Automated Quantitative Ulcer Analysis Study
|
||
Completed |
NCT02186431 -
Contact Lenses and Infiltrative Keratitis
|
N/A | |
Not yet recruiting |
NCT05689996 -
Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
|
Phase 3 |